- Home
- MED vs LXEO Comparison
MED vs LXEO Comparison
Compare MED & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MED
- LXEO
- Stock Information
- Founded
- MED 1980
- LXEO 2017
- Country
- MED United States
- LXEO United States
- Employees
- MED N/A
- LXEO N/A
- Industry
- MED Packaged Foods
- LXEO
- Sector
- MED Consumer Staples
- LXEO
- Exchange
- MED Nasdaq
- LXEO Nasdaq
- Market Cap
- MED 156.7M
- LXEO 140.6M
- IPO Year
- MED N/A
- LXEO 2023
- Fundamental
- Price
- MED $13.68
- LXEO $2.95
- Analyst Decision
- MED Hold
- LXEO Strong Buy
- Analyst Count
- MED 1
- LXEO 5
- Target Price
- MED $16.50
- LXEO $22.80
- AVG Volume (30 Days)
- MED 208.3K
- LXEO 819.0K
- Earning Date
- MED 04-28-2025
- LXEO 05-08-2025
- Dividend Yield
- MED N/A
- LXEO N/A
- EPS Growth
- MED N/A
- LXEO N/A
- EPS
- MED 0.19
- LXEO N/A
- Revenue
- MED $602,463,000.00
- LXEO N/A
- Revenue This Year
- MED N/A
- LXEO N/A
- Revenue Next Year
- MED $2.10
- LXEO N/A
- P/E Ratio
- MED $71.89
- LXEO N/A
- Revenue Growth
- MED N/A
- LXEO N/A
- 52 Week Low
- MED $12.87
- LXEO $2.32
- 52 Week High
- MED $36.30
- LXEO $19.50
- Technical
- Relative Strength Index (RSI)
- MED 43.76
- LXEO 41.97
- Support Level
- MED $12.87
- LXEO $2.90
- Resistance Level
- MED $14.07
- LXEO $4.59
- Average True Range (ATR)
- MED 0.50
- LXEO 0.52
- MACD
- MED -0.02
- LXEO 0.06
- Stochastic Oscillator
- MED 44.02
- LXEO 22.41
About MED MEDIFAST INC
Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. OPTAVIA provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. Medifast remains committed to its mission of offering Lifelong Transformation, Making a Healthy Lifestyle Second Nature.
About LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a a clinical-stage genetic medicines company dedicated to transforming healthcare by applying pioneering science to fundamentally change how disease is treated. Its pipeline consists of candidates targeting patient populations that place significant burden on society and are most amenable to their genetic medicine approach. The Company is focused on preclinical and clinical stage gene therapies, and specifically on hereditary and acquired diseases of high unmet need which is their only business segment.